Prolactinoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (31 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} | {{CMG}};{{AE}} {{Anmol}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of [[prolactinoma]] include markedly elevated [[prolactin]] levels. | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
* Prolactin | *'''Prolactin levels''' - Serum [[prolactin]] concentration may be markedly higher than normal (usually >200ng/ml). | ||
* | *'''TSH levels''' - [[Thyrotropin-releasing hormone|Thyrotropin releasing hormone]] ([[Thyrotropin-releasing hormone|TRH]]) stimulates [[prolactin]] secretion. [[Thyroid-stimulating hormone|Thyroid stimulating hormone]] ([[Thyroid-stimulating hormone|TSH]]) is measured. If [[Thyroid-stimulating hormone|TSH]] is elevated, free [[thyroxine]] ([[T4]]) level must be checked to confirm that [[Thyroid-stimulating hormone|TSH]] elevation is due to elevated [[Thyrotropin-releasing hormone|TRH]] and not due to decreased [[Thyroxine|T4]] ([[hypothyroidism]]). | ||
*'''Pregnancy test''' - A [[Pregnancy test|urine pregnancy test]] ([[beta-hCG]]) is performed as [[pregnancy]] causes a [[physiologic]] rise in [[prolactin]] levels. | |||
*'''Serum testosterone levels''' - Low levels of serum [[testosterone]] are found in males presenting with [[symptoms]] of [[hypogonadism]]. | |||
*'''IGF-1''' - [[Insulin-like growth factor-1]] levels may be done in patients with features suggestive of [[acromegaly]]. | |||
*'''Cortisol levels''' - [[Cortisol]] levels may be done in patients with features suggestive of [[Cushing's syndrome]]. | |||
*'''LFT''' - [[Liver function tests]] may be done in patients with appropriate history to exclude [[cirrhosis]] or [[viral hepatitis]] as the cause of elevated [[prolactin]]. | |||
*'''RFT''' - [[Renal function tests]] may be done in patients with appropriate history to exclude [[chronic renal failure]] as the cause of elevated [[prolactin]]. | |||
====Hook effect==== | |||
*The hook effect is a phenomenon which occurs particularly in macroprolactinoma.<ref name="pmid8729527">{{cite journal| author=St-Jean E, Blain F, Comtois R| title=High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. | journal=Clin Endocrinol (Oxf) | year= 1996 | volume= 44 | issue= 3 | pages= 305-9 | pmid=8729527 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8729527 }} </ref> | |||
*In patients with macroprolactinoma, the reading of the initial [[prolactin]] level may be normal or mildly increased. | |||
*These false values are due a large amount of [[Antigen|antigens]], so this is also called the 'high dose hook effect'. | |||
*All patients with [[pituitary]] macroadenomas should undergo an immunoradiometric [[prolactin]] assay with multiple dilutions, if [[prolactinoma]] is suspected. | |||
== References == | == References == | ||
| Line 16: | Line 27: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
| |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neuroendocrinology]] | [[Category:Neuroendocrinology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category: | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 23:49, 29 July 2020
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Prolactinoma laboratory tests |
|
Risk calculators and risk factors for Prolactinoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]
Overview
Laboratory findings consistent with the diagnosis of prolactinoma include markedly elevated prolactin levels.
Laboratory Findings
- Prolactin levels - Serum prolactin concentration may be markedly higher than normal (usually >200ng/ml).
- TSH levels - Thyrotropin releasing hormone (TRH) stimulates prolactin secretion. Thyroid stimulating hormone (TSH) is measured. If TSH is elevated, free thyroxine (T4) level must be checked to confirm that TSH elevation is due to elevated TRH and not due to decreased T4 (hypothyroidism).
- Pregnancy test - A urine pregnancy test (beta-hCG) is performed as pregnancy causes a physiologic rise in prolactin levels.
- Serum testosterone levels - Low levels of serum testosterone are found in males presenting with symptoms of hypogonadism.
- IGF-1 - Insulin-like growth factor-1 levels may be done in patients with features suggestive of acromegaly.
- Cortisol levels - Cortisol levels may be done in patients with features suggestive of Cushing's syndrome.
- LFT - Liver function tests may be done in patients with appropriate history to exclude cirrhosis or viral hepatitis as the cause of elevated prolactin.
- RFT - Renal function tests may be done in patients with appropriate history to exclude chronic renal failure as the cause of elevated prolactin.
Hook effect
- The hook effect is a phenomenon which occurs particularly in macroprolactinoma.[1]
- In patients with macroprolactinoma, the reading of the initial prolactin level may be normal or mildly increased.
- These false values are due a large amount of antigens, so this is also called the 'high dose hook effect'.
- All patients with pituitary macroadenomas should undergo an immunoradiometric prolactin assay with multiple dilutions, if prolactinoma is suspected.
References
- ↑ St-Jean E, Blain F, Comtois R (1996). "High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas". Clin Endocrinol (Oxf). 44 (3): 305–9. PMID 8729527.